Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modernizing the assessment and reporting of adverse events in oncology clinical trials using complementary statistical approaches: a case study of the MOTIVATE trial.
Morisseau M, Gomez-Roca C, Viala M, Rabeau A, Loirat D, Munsch N, Thomas K, Pages C, Korakis I, Sibaud V, Delord JP, Filleron T, Cabarrou B. Morisseau M, et al. Among authors: sibaud v. Invest New Drugs. 2024 Dec;42(6):664-674. doi: 10.1007/s10637-024-01481-9. Epub 2024 Nov 4. Invest New Drugs. 2024. PMID: 39495388
Ibrutinib-related stellar hematomas of the palms and soles.
Oillarburu N, Ysebaert L, Protin C, Ortiz-Brugues A, Baali S, Parriel E, Sibaud V. Oillarburu N, et al. Among authors: sibaud v. Am J Hematol. 2024 Nov 1. doi: 10.1002/ajh.27514. Online ahead of print. Am J Hematol. 2024. PMID: 39485009 No abstract available.
Autoimmune Skin Diseases and Immune Checkpoint Inhibitors.
Fattore D, Potestio L, Genco L, Pages C, Ortiz A, Fabbrocini G, Sibaud V. Fattore D, et al. Among authors: sibaud v. Crit Rev Immunol. 2022;42(3):11-22. doi: 10.1615/CritRevImmunol.2023047032. Crit Rev Immunol. 2022. PMID: 37017623 Review.
PATEO syndrome.
Lacroix N, Anghel D, Sibaud V. Lacroix N, et al. Among authors: sibaud v. Ann Dermatol Venereol. 2024 Jun;151(2):103267. doi: 10.1016/j.annder.2024.103267. Epub 2024 Apr 27. Ann Dermatol Venereol. 2024. PMID: 38678768 No abstract available.
Drug-induced photosensitivity associated with anticancer therapies.
Fattore D, Potestio L, Ortiz Brugués A, Sibaud V. Fattore D, et al. Among authors: sibaud v. Ital J Dermatol Venerol. 2024 Oct;159(5):555-560. doi: 10.23736/S2784-8671.24.07782-X. Epub 2024 Jun 17. Ital J Dermatol Venerol. 2024. PMID: 38884533 Free article. Review.
The urgent need of dermatologists for cancer patients in Italy.
Fattore D, Fabbrocini G, Sibaud V, Sollena P. Fattore D, et al. Among authors: sibaud v. Ital J Dermatol Venerol. 2023 Jun;158(3):274-275. doi: 10.23736/S2784-8671.23.07531-X. Epub 2023 May 10. Ital J Dermatol Venerol. 2023. PMID: 37162245 No abstract available.
Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force "Dermatology for Cancer Patients" International Study.
Sollena P, Vasiliki N, Kotteas E, Stratigos AJ, Fattore D, Orlandi A, Mannino M, Di Pumpo M, Fida M, Starace M, Apalla Z, Romano MC, Riganti J, Segura S, Martinez AF, Fabbrocini G, Sibaud V, Peris K, On Behalf Of The Eadv Task Force Dermatology For Cancer Patients. Sollena P, et al. Among authors: sibaud v. Cancers (Basel). 2023 Jul 18;15(14):3658. doi: 10.3390/cancers15143658. Cancers (Basel). 2023. PMID: 37509319 Free PMC article.
191 results